Literature DB >> 30389075

Transcranial Magnetic Stimulation in Conditions Other than Major Depressive Disorder.

Jonathan Essary Becker1, Elizabeth K B Shultz2, Christopher Todd Maley2.   

Abstract

Transcranial magnetic stimulation (TMS) is a treatment approved by the Food and Drug Administration for major depressive disorder (MDD). TMS is a neuromodulation technique that works by creating a focal magnetic field that induces a small electric current. Compared with other neuromodulation techniques, TMS is a noninvasive treatment modality that is generally well-tolerated. Because of the success of TMS in treating depression, there has been interest in applications for other neuropsychiatric diseases. The purpose of this article was to review potential uses for TMS for children and adolescents in conditions other than MDD.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Attention-deficit/hyperactivity disorder; Autism spectrum disorder; Major depressive disorder; Obsessive compulsive disorder; Schizophrenia; Transcranial magnetic stimulation

Mesh:

Year:  2018        PMID: 30389075     DOI: 10.1016/j.chc.2018.08.001

Source DB:  PubMed          Journal:  Child Adolesc Psychiatr Clin N Am        ISSN: 1056-4993


  6 in total

1.  Is Repetitive Transcranial Magnetic Stimulation (rTMS) Ready for Clinical Use as a Treatment Tool for Mental Health Targets in Children and Youth?

Authors:  Jamil Jivraj; Stephanie H Ameis
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2022-05-01

Review 2.  Electrical stimulation of cranial nerves in cognition and disease.

Authors:  Devin Adair; Dennis Truong; Zeinab Esmaeilpour; Nigel Gebodh; Helen Borges; Libby Ho; J Douglas Bremner; Bashar W Badran; Vitaly Napadow; Vincent P Clark; Marom Bikson
Journal:  Brain Stimul       Date:  2020-02-23       Impact factor: 8.955

3.  Effects of non-invasive brain stimulation in children and young people with psychiatric disorders: a protocol for a systematic review.

Authors:  Yael D Lewis; Lucy Gallop; Iain C Campbell; Ulrike Schmidt
Journal:  Syst Rev       Date:  2021-03-11

4.  Low-field magnetic stimulation improved cuprizone-induced depression-like symptoms and demyelination in female mice.

Authors:  Ali Mooshekhian; Thaisa Sandini; Zelan Wei; Rebekah Van Bruggen; Haibo Li; Xin-Min Li; Yanbo Zhang
Journal:  Exp Ther Med       Date:  2022-01-07       Impact factor: 2.447

Review 5.  Current challenges and possible future developments in personalized psychiatry with an emphasis on psychotic disorders.

Authors:  Anastasia Levchenko; Timur Nurgaliev; Alexander Kanapin; Anastasia Samsonova; Raul R Gainetdinov
Journal:  Heliyon       Date:  2020-05-20

6.  The Regenerative Effect of Trans-spinal Magnetic Stimulation After Spinal Cord Injury: Mechanisms and Pathways Underlying the Effect.

Authors:  C Chalfouh; C Guillou; J Hardouin; Q Delarue; X Li; C Duclos; D Schapman; J-P Marie; P Cosette; N Guérout
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.